St. Jude Medical, LLC Sustainability Profile
St. Jude Medical, LLC, a prominent player in the medical device industry, is headquartered in the United States. Founded in 1976, the company has established itself as a leader in developing innovative solutions for cardiovascular, neuromodulation, and electrophysiology markets. With a strong presence in North America, Europe, and Asia, St. Jude Medical focuses on advanced technologies that enhance patient care and improve clinical outcomes. The company’s core products include cardiac rhythm management devices, heart valves, and neurostimulation systems, all designed with a commitment to quality and innovation. St. Jude Medical is recognised for its pioneering contributions to minimally invasive procedures and its dedication to research and development. With numerous accolades and a solid market position, St. Jude Medical continues to shape the future of healthcare through its cutting-edge medical technologies.
DitchCarbon Score
How does St. Jude Medical, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
St. Jude Medical, LLC's score of 59 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
St. Jude Medical, LLC, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Abbott Laboratories, which influences its climate commitments and reporting practices. St. Jude Medical's climate initiatives and reduction targets are inherited from Abbott Laboratories. Abbott has established science-based targets for emissions reductions, which are cascaded down to its subsidiaries, including St. Jude Medical. However, specific reduction targets for St. Jude Medical are not detailed in the available data. As part of its commitment to sustainability, Abbott Laboratories participates in various climate initiatives, including the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). These initiatives aim to enhance transparency and accountability in emissions reporting and reduction efforts across the corporate family. In summary, while St. Jude Medical does not provide specific emissions data or reduction targets, it aligns with the broader climate commitments set forth by its parent company, Abbott Laboratories, reflecting a commitment to addressing climate change within the medical technology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 578,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 691,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - | - | - | 0,000,000,000 |
How Carbon Intensive is St. Jude Medical, LLC's Industry?
How Carbon Intensive is St. Jude Medical, LLC's Location?
St. Jude Medical, LLC's Scope 3 Categories Breakdown
The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.
Top Scope 3 Categories
St. Jude Medical, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
St. Jude Medical, LLC has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.